Ulinastatin for injection obtained clinical trial approval

Aidea Pharma completed the shareholding reorganization and was renamed as "Jiangsu Aidea Pharmaceutical Co., Ltd.".

ACC008 was included into the national 13th Five-Year Plan Science and Technology Major Projects as "Major New Drug Development".

ACC010 obtained clinical trial approval.

Nanjing Accelas Pharmaceutical Technology Co., Ltd. was recognized as one of the Nanjing Antiviral Drug R&D Engineering and Technology Research Centers.